DN4 Pharmacoecononomic Evaluation of Sedation with Remifentanil/Propofolversus Midazolam/Fentanyl in the Intensive Care Unit (original) (raw)
Insulin Glargine in the intensive care unit: A model-based clinical trial design
Normy Razak
Biomedical Signal Processing and Control, 2013
View PDFchevron_right
Hypoglycemia risk: A cause for concern in the intensive care unit hyperglycemia control debate
Jose Yataco, Nancy Freire
Critical Care Medicine, 2007
View PDFchevron_right
Cost Analysis of Intensive Glycemic Control in Critically Ill Adult Patients
James Krinsley
Chest, 2006
View PDFchevron_right
Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial
Bernd Muellejans
Critical care (London, England), 2006
View PDFchevron_right
I-SAVE Study: Impact of Sedation, Analgesia, and Delirium Protocols Evaluated in the Intensive Care Unit: An Economic Evaluation
Jean Lachaîne, Y. Skrobik
Annals of Pharmacotherapy, 2012
View PDFchevron_right
Clinical review: Strict or loose glycemic control in critically ill patients - implementing best available evidence from randomized controlled trials
Peter Spronk
Critical Care, 2010
View PDFchevron_right
Perioperative glycemic management in 2011
Shamsuddin Akhtar
Current Opinion in Critical Care, 2011
View PDFchevron_right
A Prospective Evaluation of Empiric versus Protocol-Based Sedation and Analgesia
Ward Patrick
Pharmacotherapy, 2000
View PDFchevron_right
Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands
Maiwenn Al
Critical Care, 2010
View PDFchevron_right
Second pilot trials of the STAR-Liege protocol for tight glycemic control in critically ill patients
Paul Massion
BioMedical Engineering OnLine, 2012
View PDFchevron_right
Society of hospital medicine glycemic control task force summary: Practical recommendations for assessing the impact of glycemic control efforts
Kevin Larsen
Journal of Hospital Medicine, 2008
View PDFchevron_right
ICU Volume 15-Issue 3-2015-Matrix Critically Ill Diabetic Patients
Francesca Di Muzio
2021
View PDFchevron_right
Research Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial
Bernd Muellejans
Crit Care, 2006
View PDFchevron_right
Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical care
Michael F Mascia
Critical Care Medicine, 2000
View PDFchevron_right
Safety and Efficacy of Personalized Glycemic Control in Critically Ill Patients: A 2-YEAR Before and After Interventional Trial
James Krinsley
Endocrine Practice
View PDFchevron_right
Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial
Pablo Alemán
Critical Care, 2008
View PDFchevron_right
Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)
Maria Raikou
BMJ, 2000
View PDFchevron_right
Outcomes of “Real-World” Insulin Strategies in the Management of Hospital Hyperglycemia
Aisha Vadhariya
Journal of the Endocrine Society, 2021
View PDFchevron_right
Intensive versus conventional glucose control in critically ill patients: A meta-analysis of randomized controlled trials
Cindy Gao
European Journal of Internal Medicine, 2012
View PDFchevron_right
Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action
Cecilia C Low Wang
Diabetes Care, 2013
View PDFchevron_right
International recommendations for glucose control in adult non diabetic critically ill patients
Jean-charles Preiser
Critical care (London, England), 2010
View PDFchevron_right
Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK
paul holmes
Current Medical Research and Opinion, 2007
View PDFchevron_right
Impact of prolonged requirement for insulin on 90-day mortality in critically ill patients without previous diabetic treatments: a post hoc analysis of the CONTROLING randomized control trial
Ali Ait Hssain
Critical Care
View PDFchevron_right
Strict glycemic control in patients hospitalized in a mixed medical and surgical intensive care unit: a randomized clinical trial
Clara Arango
Critical Care, 2008
View PDFchevron_right
Relationship Between Standardized Glycemic Protocols and Healthcare Cost
Karen Yehle
Clinical Nursing Research, 2014
View PDFchevron_right
A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit*
Jyoti Aggarwal
Critical Care Medicine, 2010
View PDFchevron_right
In-hospital Management of Diabetes
Robyn Houlden
Canadian Journal of Diabetes, 2013
View PDFchevron_right